JP2024528893A - 網膜神経変性を予防するための組成物及び方法 - Google Patents

網膜神経変性を予防するための組成物及び方法 Download PDF

Info

Publication number
JP2024528893A
JP2024528893A JP2024505093A JP2024505093A JP2024528893A JP 2024528893 A JP2024528893 A JP 2024528893A JP 2024505093 A JP2024505093 A JP 2024505093A JP 2024505093 A JP2024505093 A JP 2024505093A JP 2024528893 A JP2024528893 A JP 2024528893A
Authority
JP
Japan
Prior art keywords
apom
present disclosure
methods
compositions
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024505093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528893A5 (https=
Inventor
アプテ、ラジェンドラ
ジャヴァエリ、アリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University in St Louis WUSTL filed Critical Washington University in St Louis WUSTL
Publication of JP2024528893A publication Critical patent/JP2024528893A/ja
Publication of JP2024528893A5 publication Critical patent/JP2024528893A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024505093A 2021-07-28 2022-07-26 網膜神経変性を予防するための組成物及び方法 Pending JP2024528893A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163226756P 2021-07-28 2021-07-28
US63/226,756 2021-07-28
PCT/US2022/038278 WO2023009479A1 (en) 2021-07-28 2022-07-26 Compositions and methods for prevention of retinal neurodegeneration

Publications (2)

Publication Number Publication Date
JP2024528893A true JP2024528893A (ja) 2024-08-01
JP2024528893A5 JP2024528893A5 (https=) 2025-07-29

Family

ID=85087191

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024505093A Pending JP2024528893A (ja) 2021-07-28 2022-07-26 網膜神経変性を予防するための組成物及び方法

Country Status (5)

Country Link
US (1) US20240350582A1 (https=)
EP (1) EP4376868A4 (https=)
JP (1) JP2024528893A (https=)
CA (1) CA3227609A1 (https=)
WO (1) WO2023009479A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017510296A (ja) * 2014-03-17 2017-04-13 アドヴェラム バイオテクノロジーズ， インコーポレイテッド 錐体細胞における増強された遺伝子発現のための組成物および方法
CN109303782A (zh) * 2018-10-24 2019-02-05 厦门大学 Jnk-in-8在制备干性年龄相关性黄斑变性的神经保护剂中的应用
JP2020531010A (ja) * 2017-08-15 2020-11-05 ザ チルドレンズ メディカル センター コーポレーション ＡｐｏＭ−Ｆｃ融合タンパク質およびその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9592268B2 (en) * 2011-05-23 2017-03-14 Cornell University Endothelium protective materials and methods of use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017510296A (ja) * 2014-03-17 2017-04-13 アドヴェラム バイオテクノロジーズ， インコーポレイテッド 錐体細胞における増強された遺伝子発現のための組成物および方法
JP2020531010A (ja) * 2017-08-15 2020-11-05 ザ チルドレンズ メディカル センター コーポレーション ＡｐｏＭ−Ｆｃ融合タンパク質およびその使用
CN109303782A (zh) * 2018-10-24 2019-02-05 厦门大学 Jnk-in-8在制备干性年龄相关性黄斑变性的神经保护剂中的应用

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BRITISH JOURNAL OF OPHTHALMOLOGY, vol. 106, no. 9, JPN6026005777, 7 May 2021 (2021-05-07), pages 1187 - 1195, ISSN: 0005797443 *
EYE, vol. 24, JPN6026005778, 2010, pages 416 - 421, ISSN: 0005797444 *
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 19, no. 112, JPN6026005771, 2018, ISSN: 0005797437 *
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 35, no. 1, JPN6026005776, 1994, ISSN: 0005797442 *
OPHTHALMIC & PHYSIOLOGICAL OPTICS, vol. 40, JPN6026005774, 2020, pages 140 - 170, ISSN: 0005797440 *
PROSTAGLANDINS AND OTHERS LIPID MEDIATORS, vol. 145, no. 106365, JPN6026005775, 2019, ISSN: 0005797441 *
眼科疾患分野 血管新生黄斑症（平成22年度）, JPN6026005773, 15 June 2021 (2021-06-15), ISSN: 0005797439 *
順天堂医学, vol. 43, no. 3, JPN6026005772, 1997, ISSN: 0005797438 *

Also Published As

Publication number Publication date
US20240350582A1 (en) 2024-10-24
CA3227609A1 (en) 2023-02-02
EP4376868A4 (en) 2025-05-14
WO2023009479A1 (en) 2023-02-02
EP4376868A1 (en) 2024-06-05

Similar Documents

Publication Publication Date Title
US11339410B2 (en) Methods and products for expressing proteins in cells
Rossmiller et al. Gene therapy in animal models of autosomal dominant retinitis pigmentosa
Ratican et al. Progress in gene therapy to prevent retinal ganglion cell loss in glaucoma and Leber’s hereditary optic neuropathy
Khalin et al. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
US20110021605A1 (en) Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
US10584341B2 (en) Antagonistic PDL1 aptamers and their applications in cancer therapy
TWI703214B (zh) 具拮抗ｐｄ-１功能的適體分子於癌症治療相關之應用
US20140148501A1 (en) Dna aptamers for promoting remyelination
Altay et al. Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial
JP6702938B2 (ja) アンタゴニストｉｃ ｃｔｌａ−４アプタマー及びその免疫活性増強への応用
Kim Novel approaches for retinal drug and gene delivery
AU2021205373B2 (en) Composition for preventing or treating macular degeneration, containing cell permeable nucleic acid complex as active ingredient
JP2024528893A (ja) 網膜神経変性を予防するための組成物及び方法
US20220211624A1 (en) Fusion protein nanodisk compositions and methods of treatment
US11098296B2 (en) Mutants of cocaine esterase
Wu et al. Engineered virus-like particle-assembled Vegfa-targeting Cas9 ribonucleoprotein treatment alleviates neovascularization in wet age-related macular degeneration
US20240424030A1 (en) Compositions, systems, and methods related to transgenic hookworms as a drug production and delivery technology
US20240050435A1 (en) Methods for treating cancer
CA3190597A1 (en) Compositions and methods for the treatment of ocular neuroinflammation
US20240415930A1 (en) Compositions and methods for enhancing brain perfusion
KR20220026197A (ko) 세포 투과성 핵산 복합체를 유효성분으로 함유하는 류마티스 관절염의 예방 또는 치료용 조성물
CA3163848C (en) Composition for preventing or treating macular degeneration, containing cell permeable nucleic acid complex as active ingredient
US20250144043A1 (en) Methods of assessing cancer
HK40076771A (en) Composition for preventing or treating macular degeneration, containing cell permeable nucleic acid complex as active ingredient

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250718

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250718

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260217